Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-29

Clinical Trial Update: TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tranexamic acid to prevent postpartum hemorrhage after cesarean delivery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Postpartum Hemorrhage | Phase 3 | Status: COMPLETED